Stem Cell Therapy and IVF: The Science Behind India's First Stem Cell Baby

In 2018, Solo Clinic IVF & ObGyn achieved two milestones that placed India at the global frontier of reproductive medicine. Under the leadership of Dr. Sunita Tandulwadkar, the clinic delivered India's first stem cell baby — and separately accomplished the world's first successful stem cell-assisted conception in a 45-year-old woman. These achievements did not happen by chance. They represent the outcome of more than a decade of careful, evidence-guided exploration of stem cell biology in human reproduction, pursued within rigorous scientific and ethical frameworks.

This article explains what stem cells are, the science behind their application in reproductive medicine, what the landmark achievements at Solo Clinic represent, where the field is today, and what realistic expectations look like for the future.

What Are Stem Cells?

Stem cells are undifferentiated cells with two defining properties: the capacity for self-renewal (they can divide to produce identical copies of themselves) and the potential for differentiation (under appropriate conditions, they can develop into specialised cell types). They are found throughout the body at various stages of differentiation — from the totipotent cells of the early embryo (which can become any cell type) to adult tissue-specific stem cells that repair and replenish specific organs.

In reproductive medicine, interest has focused primarily on two adult stem cell populations:

• Ovarian stem cells (oogonial stem cells or germline stem cells): A population of cells in the ovarian cortex that may retain some capacity for generating new oocytes in postnatal life — a finding that has challenged the classical dogma that women are born with all the eggs they will ever have.
• Mesenchymal stem cells (MSCs): Found in bone marrow, adipose tissue, umbilical cord blood, and other sources. Capable of differentiating into multiple cell types and of secreting trophic factors that support tissue repair and regeneration.

The Scientific Rationale: Why Stem Cells for Fertility?

The driving clinical problem is straightforward: some women have severely diminished or absent ovarian reserve — whether from premature ovarian insufficiency (POI), previous surgery, chemotherapy, radiation, or age-related decline — and have no viable path to pregnancy with their own genetic material using current IVF technology. Donor egg IVF remains the most reliable alternative, but some women wish to explore whether their own ovarian biology can be reactivated.

The stem cell hypothesis in ovarian medicine is that injecting stem cells — or the growth factors they secrete — into the ovarian cortex may:

• Activate dormant primordial follicles that are present but not being recruited
• Provide trophic support that improves the local hormonal and metabolic environment for follicle survival and development
• In some models, generate new germ cells from oogonial stem cells, though this remains scientifically debated

Whether the mechanism is genuine de novo oocyte generation or rescue of existing dormant follicles is still not settled science. What clinical data shows — in carefully selected cases — is that some women with previously absent or undetectable AMH have shown measurable AMH rises and antral follicles following stem cell-assisted protocols, with successful egg retrieval and, in documented cases, live births.

The Landmark Achievements at Solo Clinic

India's First Stem Cell Baby

Dr. Tandulwadkar's team achieved the first IVF-stem cell supported conception and live birth in India. This accomplishment required not only clinical innovation but extensive collaboration with basic science researchers, embryologists, laboratory specialists, and the ethics committee infrastructure appropriate for investigational protocols. The result was a healthy baby born to a patient for whom conventional IVF had not been successful — demonstrating in a real clinical outcome that stem cell-assisted reproductive protocols can work in the Indian setting.

World's First Stem Cell Conception at 45

In 2018, the team documented the world's first successful stem cell-assisted conception in a woman aged 45. At 45, the expected outcome with conventional IVF using own eggs is very limited — live birth rates per cycle are typically below 5 to 10%, and the probability of producing chromosomally normal embryos is very low. This case represented a genuine departure: a woman for whom the standard clinical advice would have been donor egg IVF achieved a pregnancy with her own genetic material through a stem cell-assisted protocol.

This is not a universal solution. It is not a procedure offered to all patients at 45. It represents what is possible in carefully selected, consented patients who have residual ovarian biology that can be coaxed into a response that standard stimulation cannot produce. It was accomplished with appropriate scientific rigour and within an ethical framework that respected the experimental nature of the intervention.

How Stem Cell-Assisted IVF Works: The Protocol

The general framework of stem cell-assisted IVF protocols, as developed at Solo Clinic and reported in the scientific literature, involves:

• Patient selection: Women with severe DOR (very low or undetectable AMH, very low or absent AFC) who have not responded to standard stimulation but who have some evidence of residual ovarian biology.
• Stem cell preparation: Autologous stem cells (from the patient's own bone marrow or peripheral blood after mobilisation with growth factors) are harvested and concentrated. In some protocols, platelet-rich plasma is used as the delivery vehicle.
• Intra-ovarian administration: The stem cell preparation is delivered into the ovarian cortex, either by direct injection under ultrasound guidance or by intra-ovarian infusion.
• Monitoring: Serial AMH measurements and antral follicle counts at intervals (typically monthly) to detect any ovarian response.
• IVF if response occurs: If AMH rises and follicles become visible, IVF stimulation is attempted. Retrieved eggs are fertilised by ICSI and the resulting embryos transferred.

Response is not guaranteed and does not occur in all patients. The proportion who show a measurable ovarian response varies by series and patient selection criteria. The proportion of responders who successfully complete IVF and achieve a live birth is smaller still. This honest presentation of outcome probability is essential to ethical stem cell programme management.

The Regulatory Framework in India

Stem cell therapies in India are regulated by guidelines from the ICMR (Indian Council of Medical Research) and CDSCO (Central Drugs Standard Control Organisation). Applications of stem cells in reproductive medicine that go beyond established guidelines require ethics committee approval and are conducted within research frameworks. At Solo Clinic, all stem cell-related work is conducted with appropriate regulatory and ethical oversight — not as commercial off-the-shelf procedures.

Patients considering stem cell-assisted IVF should always ask: Is this protocol ethics committee-approved? Is the outcome data from your clinic documented and available? Is the experimental nature of this treatment being disclosed? These questions are not hostile — they are the markers of a legitimate programme.

Where Is Stem Cell Reproductive Medicine Heading?

The field is advancing on several fronts:

• Larger, more rigorously designed clinical trials of intraovarian stem cell injection for POI — moving from case series to controlled evidence.
• Endometrial regeneration using stem cells for severe Asherman's syndrome — documented live births have been reported.
• Mitochondrial support technologies (including nuclear transfer and spindle transfer) for improving egg quality in older women — under active investigation in several research centres.
• Better characterisation of oogonial stem cells and their true regenerative capacity — an ongoing scientific debate.

The realistic expectation for the next decade: stem cell approaches will become a meaningful, validated option for carefully selected patients who currently have no viable alternative — not a universal IVF enhancement or a replacement for conventional ART.

Frequently Asked Questions

Q1. Is stem cell IVF available at Solo Clinic?

Yes — within appropriate clinical and research frameworks and for carefully selected patients. Dr. Tandulwadkar's team has direct clinical experience with stem cell-assisted reproductive protocols. Patients who may be candidates are assessed individually, with full, transparent disclosure of what is known about the procedure, what the realistic success probability is, and what alternatives exist. This is not offered as a standard add-on to all IVF cycles.

Q2. Can stem cell therapy help women with POI?

In carefully selected cases where there is evidence of residual ovarian biology — detectable AMH, however low, or any visible AFC — stem cell protocols have produced measurable responses in some patients. For women with truly complete POI (zero follicular activity confirmed by repeated testing), the evidence of benefit is weaker and donor egg IVF remains the most reliable path.

Q3. How much does stem cell-assisted IVF cost?

The cost of stem cell-assisted IVF at Solo Clinic is discussed in the context of a comprehensive clinical consultation — not quoted as a package price on a website. It includes the stem cell preparation procedure, monitoring, and IVF cycle costs. This is not an inexpensive intervention. The financial investment must be weighed against realistic success probability, and the comparison with donor egg IVF (which is well-documented and has established success rates) should be part of the counselling conversation.

DISCLAIMER: This article is for educational purposes only. Regenerative approaches in reproductive medicine are largely adjunctive and some remain investigational. Consult Dr. Sunita Tandulwadkar or a qualified specialist for personalised guidance. Solo Clinic IVF & ObGyn, Pune.